Chronic Disease Management Market Dynamics 2021-2031
Chronic diseases are long-term clinical conditions that grow over time. It is considered an expensive and most prevalent health care issue across the world. Therefore, digital healthcare facilities include providing healthcare officials with educational insights to their patients, applying patient-specific and disease-specific treatment options and plans. These services are specifically designed for managing chronic diseases and reducing their severity in patients.
MARKET DYNAMICS
The chronic disease management market is expected to grow significantly in the coming years, due to rise in the number of the patients suffering from chronic diseases, uneven climatic conditions and more. Moreover, advancement in the information technology to influence the end-user.
MARKET SCOPE
The "Chronic Disease Management Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Chronic Disease Management market with detailed market segmentation by Disease Type, Service Type, Deployment Model and End-User. The Chronic Disease Management market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Chronic Disease Management market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Chronic Disease Management market is segmented on the basis of by Disease Type, Service Type, Deployment Model and End-User. Based on Disease Type , the market is segmented into Diabetes, Cancer, Cardiovascular Diseases (CVD), Asthma, Arthritis, , Chronic Obstructive Pulmonary Disorders (COPD), Stroke, Others. On the basis of Service Type, the market is categorized as Consulting Service, Implementation Service, Educational Services, Others. On the basis of Deployment Mode, the market is categorized as On-Premise, Cloud-Based, Web-Based. On the basis off end-user, the market is categorized as Provider, Payer, Others
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Chronic Disease Management market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Chronic Disease Management market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Chronic Disease Management market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Chronic Disease Management market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Chronic Disease Management market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Chronic Disease Management market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Chronic Disease Management market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Chronic Disease Management market in these regions.
MARKET PLAYERS
The report covers key developments in the Chronic Disease Management market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Chronic Disease Management market are anticipated to have lucrative growth opportunities in the future with the rising demand for Chronic Disease Management in the global market. Below mentioned is the list of few companies engaged in the Chronic Disease Management market.
The report also includes the profiles of key players in Chronic Disease Management market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Allscripts
- ScienceSoft USA Corporation
- Siemens Healthcare Private Limited
- Koninklijke Philips N.V
- MINES & Associates, Inc.;
- Mediware Information Systems
- Pegasystems Inc.
- HealthCare atHOME
- Cognizant TriZetto Software Group, Inc
- IBM Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chronic Disease Management Market - By Disease Type
1.3.2 Chronic Disease Management Market - By Service Type
1.3.3 Chronic Disease Management Market - By Deployment Mode
1.3.4 Chronic Disease Management Market - By End-User
1.3.5 Chronic Disease Management Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHRONIC DISEASE MANAGEMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHRONIC DISEASE MANAGEMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHRONIC DISEASE MANAGEMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. CHRONIC DISEASE MANAGEMENT - GLOBAL MARKET OVERVIEW
6.2. CHRONIC DISEASE MANAGEMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CHRONIC DISEASE MANAGEMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. DIABETES
7.3.1. Overview
7.3.2. Diabetes Market Forecast and Analysis
7.4. CANCER
7.4.1. Overview
7.4.2. Cancer Market Forecast and Analysis
7.5. CARDIOVASCULAR DISEASES (CVD)
7.5.1. Overview
7.5.2. Cardiovascular Diseases (CVD) Market Forecast and Analysis
7.6. ASTHMA
7.6.1. Overview
7.6.2. Asthma Market Forecast and Analysis
7.7. ARTHRITIS
7.7.1. Overview
7.7.2. Arthritis Market Forecast and Analysis
7.8. CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD)
7.8.1. Overview
7.8.2. Chronic Obstructive Pulmonary Disorders (COPD) Market Forecast and Analysis
7.9. STROKE
7.9.1. Overview
7.9.2. Stroke Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. Others Market Forecast and Analysis
8. CHRONIC DISEASE MANAGEMENT MARKET - REVENUE AND FORECASTS TO 2028 - SERVICE TYPE
8.1. OVERVIEW
8.2. SERVICE TYPE MARKET FORECASTS AND ANALYSIS
8.3. CONSULTING SERVICE
8.3.1. Overview
8.3.2. Consulting Service Market Forecast and Analysis
8.4. IMPLEMENTATION SERVICE
8.4.1. Overview
8.4.2. Implementation Service Market Forecast and Analysis
8.5. EDUCATIONAL SERVICES
8.5.1. Overview
8.5.2. Educational Services Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. CHRONIC DISEASE MANAGEMENT MARKET - REVENUE AND FORECASTS TO 2028 - DEPLOYMENT MODE
9.1. OVERVIEW
9.2. DEPLOYMENT MODE MARKET FORECASTS AND ANALYSIS
9.3. ON-PREMISE
9.3.1. Overview
9.3.2. On-Premise Market Forecast and Analysis
9.4. CLOUD-BASED
9.4.1. Overview
9.4.2. Cloud-Based Market Forecast and Analysis
9.5. WEB-BASED
9.5.1. Overview
9.5.2. Web-Based Market Forecast and Analysis
10. CHRONIC DISEASE MANAGEMENT MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. PROVIDER
10.3.1. Overview
10.3.2. Provider Market Forecast and Analysis
10.4. PAYER
10.4.1. Overview
10.4.2. Payer Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. CHRONIC DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Chronic Disease Management Market Overview
11.1.2 North America Chronic Disease Management Market Forecasts and Analysis
11.1.3 North America Chronic Disease Management Market Forecasts and Analysis - By Disease Type
11.1.4 North America Chronic Disease Management Market Forecasts and Analysis - By Service Type
11.1.5 North America Chronic Disease Management Market Forecasts and Analysis - By Deployment Mode
11.1.6 North America Chronic Disease Management Market Forecasts and Analysis - By End-User
11.1.7 North America Chronic Disease Management Market Forecasts and Analysis - By Countries
11.1.7.1 United States Chronic Disease Management Market
11.1.7.1.1 United States Chronic Disease Management Market by Disease Type
11.1.7.1.2 United States Chronic Disease Management Market by Service Type
11.1.7.1.3 United States Chronic Disease Management Market by Deployment Mode
11.1.7.1.4 United States Chronic Disease Management Market by End-User
11.1.7.2 Canada Chronic Disease Management Market
11.1.7.2.1 Canada Chronic Disease Management Market by Disease Type
11.1.7.2.2 Canada Chronic Disease Management Market by Service Type
11.1.7.2.3 Canada Chronic Disease Management Market by Deployment Mode
11.1.7.2.4 Canada Chronic Disease Management Market by End-User
11.1.7.3 Mexico Chronic Disease Management Market
11.1.7.3.1 Mexico Chronic Disease Management Market by Disease Type
11.1.7.3.2 Mexico Chronic Disease Management Market by Service Type
11.1.7.3.3 Mexico Chronic Disease Management Market by Deployment Mode
11.1.7.3.4 Mexico Chronic Disease Management Market by End-User
11.2. EUROPE
11.2.1 Europe Chronic Disease Management Market Overview
11.2.2 Europe Chronic Disease Management Market Forecasts and Analysis
11.2.3 Europe Chronic Disease Management Market Forecasts and Analysis - By Disease Type
11.2.4 Europe Chronic Disease Management Market Forecasts and Analysis - By Service Type
11.2.5 Europe Chronic Disease Management Market Forecasts and Analysis - By Deployment Mode
11.2.6 Europe Chronic Disease Management Market Forecasts and Analysis - By End-User
11.2.7 Europe Chronic Disease Management Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Chronic Disease Management Market
11.2.7.1.1 Germany Chronic Disease Management Market by Disease Type
11.2.7.1.2 Germany Chronic Disease Management Market by Service Type
11.2.7.1.3 Germany Chronic Disease Management Market by Deployment Mode
11.2.7.1.4 Germany Chronic Disease Management Market by End-User
11.2.7.2 France Chronic Disease Management Market
11.2.7.2.1 France Chronic Disease Management Market by Disease Type
11.2.7.2.2 France Chronic Disease Management Market by Service Type
11.2.7.2.3 France Chronic Disease Management Market by Deployment Mode
11.2.7.2.4 France Chronic Disease Management Market by End-User
11.2.7.3 Italy Chronic Disease Management Market
11.2.7.3.1 Italy Chronic Disease Management Market by Disease Type
11.2.7.3.2 Italy Chronic Disease Management Market by Service Type
11.2.7.3.3 Italy Chronic Disease Management Market by Deployment Mode
11.2.7.3.4 Italy Chronic Disease Management Market by End-User
11.2.7.4 Spain Chronic Disease Management Market
11.2.7.4.1 Spain Chronic Disease Management Market by Disease Type
11.2.7.4.2 Spain Chronic Disease Management Market by Service Type
11.2.7.4.3 Spain Chronic Disease Management Market by Deployment Mode
11.2.7.4.4 Spain Chronic Disease Management Market by End-User
11.2.7.5 United Kingdom Chronic Disease Management Market
11.2.7.5.1 United Kingdom Chronic Disease Management Market by Disease Type
11.2.7.5.2 United Kingdom Chronic Disease Management Market by Service Type
11.2.7.5.3 United Kingdom Chronic Disease Management Market by Deployment Mode
11.2.7.5.4 United Kingdom Chronic Disease Management Market by End-User
11.2.7.6 Rest of Europe Chronic Disease Management Market
11.2.7.6.1 Rest of Europe Chronic Disease Management Market by Disease Type
11.2.7.6.2 Rest of Europe Chronic Disease Management Market by Service Type
11.2.7.6.3 Rest of Europe Chronic Disease Management Market by Deployment Mode
11.2.7.6.4 Rest of Europe Chronic Disease Management Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Chronic Disease Management Market Overview
11.3.2 Asia-Pacific Chronic Disease Management Market Forecasts and Analysis
11.3.3 Asia-Pacific Chronic Disease Management Market Forecasts and Analysis - By Disease Type
11.3.4 Asia-Pacific Chronic Disease Management Market Forecasts and Analysis - By Service Type
11.3.5 Asia-Pacific Chronic Disease Management Market Forecasts and Analysis - By Deployment Mode
11.3.6 Asia-Pacific Chronic Disease Management Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Chronic Disease Management Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Chronic Disease Management Market
11.3.7.1.1 Australia Chronic Disease Management Market by Disease Type
11.3.7.1.2 Australia Chronic Disease Management Market by Service Type
11.3.7.1.3 Australia Chronic Disease Management Market by Deployment Mode
11.3.7.1.4 Australia Chronic Disease Management Market by End-User
11.3.7.2 China Chronic Disease Management Market
11.3.7.2.1 China Chronic Disease Management Market by Disease Type
11.3.7.2.2 China Chronic Disease Management Market by Service Type
11.3.7.2.3 China Chronic Disease Management Market by Deployment Mode
11.3.7.2.4 China Chronic Disease Management Market by End-User
11.3.7.3 India Chronic Disease Management Market
11.3.7.3.1 India Chronic Disease Management Market by Disease Type
11.3.7.3.2 India Chronic Disease Management Market by Service Type
11.3.7.3.3 India Chronic Disease Management Market by Deployment Mode
11.3.7.3.4 India Chronic Disease Management Market by End-User
11.3.7.4 Japan Chronic Disease Management Market
11.3.7.4.1 Japan Chronic Disease Management Market by Disease Type
11.3.7.4.2 Japan Chronic Disease Management Market by Service Type
11.3.7.4.3 Japan Chronic Disease Management Market by Deployment Mode
11.3.7.4.4 Japan Chronic Disease Management Market by End-User
11.3.7.5 South Korea Chronic Disease Management Market
11.3.7.5.1 South Korea Chronic Disease Management Market by Disease Type
11.3.7.5.2 South Korea Chronic Disease Management Market by Service Type
11.3.7.5.3 South Korea Chronic Disease Management Market by Deployment Mode
11.3.7.5.4 South Korea Chronic Disease Management Market by End-User
11.3.7.6 Rest of Asia-Pacific Chronic Disease Management Market
11.3.7.6.1 Rest of Asia-Pacific Chronic Disease Management Market by Disease Type
11.3.7.6.2 Rest of Asia-Pacific Chronic Disease Management Market by Service Type
11.3.7.6.3 Rest of Asia-Pacific Chronic Disease Management Market by Deployment Mode
11.3.7.6.4 Rest of Asia-Pacific Chronic Disease Management Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Chronic Disease Management Market Overview
11.4.2 Middle East and Africa Chronic Disease Management Market Forecasts and Analysis
11.4.3 Middle East and Africa Chronic Disease Management Market Forecasts and Analysis - By Disease Type
11.4.4 Middle East and Africa Chronic Disease Management Market Forecasts and Analysis - By Service Type
11.4.5 Middle East and Africa Chronic Disease Management Market Forecasts and Analysis - By Deployment Mode
11.4.6 Middle East and Africa Chronic Disease Management Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Chronic Disease Management Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Chronic Disease Management Market
11.4.7.1.1 South Africa Chronic Disease Management Market by Disease Type
11.4.7.1.2 South Africa Chronic Disease Management Market by Service Type
11.4.7.1.3 South Africa Chronic Disease Management Market by Deployment Mode
11.4.7.1.4 South Africa Chronic Disease Management Market by End-User
11.4.7.2 Saudi Arabia Chronic Disease Management Market
11.4.7.2.1 Saudi Arabia Chronic Disease Management Market by Disease Type
11.4.7.2.2 Saudi Arabia Chronic Disease Management Market by Service Type
11.4.7.2.3 Saudi Arabia Chronic Disease Management Market by Deployment Mode
11.4.7.2.4 Saudi Arabia Chronic Disease Management Market by End-User
11.4.7.3 U.A.E Chronic Disease Management Market
11.4.7.3.1 U.A.E Chronic Disease Management Market by Disease Type
11.4.7.3.2 U.A.E Chronic Disease Management Market by Service Type
11.4.7.3.3 U.A.E Chronic Disease Management Market by Deployment Mode
11.4.7.3.4 U.A.E Chronic Disease Management Market by End-User
11.4.7.4 Rest of Middle East and Africa Chronic Disease Management Market
11.4.7.4.1 Rest of Middle East and Africa Chronic Disease Management Market by Disease Type
11.4.7.4.2 Rest of Middle East and Africa Chronic Disease Management Market by Service Type
11.4.7.4.3 Rest of Middle East and Africa Chronic Disease Management Market by Deployment Mode
11.4.7.4.4 Rest of Middle East and Africa Chronic Disease Management Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Chronic Disease Management Market Overview
11.5.2 South and Central America Chronic Disease Management Market Forecasts and Analysis
11.5.3 South and Central America Chronic Disease Management Market Forecasts and Analysis - By Disease Type
11.5.4 South and Central America Chronic Disease Management Market Forecasts and Analysis - By Service Type
11.5.5 South and Central America Chronic Disease Management Market Forecasts and Analysis - By Deployment Mode
11.5.6 South and Central America Chronic Disease Management Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Chronic Disease Management Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Chronic Disease Management Market
11.5.7.1.1 Brazil Chronic Disease Management Market by Disease Type
11.5.7.1.2 Brazil Chronic Disease Management Market by Service Type
11.5.7.1.3 Brazil Chronic Disease Management Market by Deployment Mode
11.5.7.1.4 Brazil Chronic Disease Management Market by End-User
11.5.7.2 Argentina Chronic Disease Management Market
11.5.7.2.1 Argentina Chronic Disease Management Market by Disease Type
11.5.7.2.2 Argentina Chronic Disease Management Market by Service Type
11.5.7.2.3 Argentina Chronic Disease Management Market by Deployment Mode
11.5.7.2.4 Argentina Chronic Disease Management Market by End-User
11.5.7.3 Rest of South and Central America Chronic Disease Management Market
11.5.7.3.1 Rest of South and Central America Chronic Disease Management Market by Disease Type
11.5.7.3.2 Rest of South and Central America Chronic Disease Management Market by Service Type
11.5.7.3.3 Rest of South and Central America Chronic Disease Management Market by Deployment Mode
11.5.7.3.4 Rest of South and Central America Chronic Disease Management Market by End-User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CHRONIC DISEASE MANAGEMENT MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest of the World
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. CHRONIC DISEASE MANAGEMENT MARKET, KEY COMPANY PROFILES
14.1. ALLSCRIPTS
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. SCIENCESOFT USA CORPORATION
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. SIEMENS HEALTHCARE PRIVATE LIMITED
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. KONINKLIJKE PHILIPS N.V
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. MINES AND ASSOCIATES, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MEDIWARE INFORMATION SYSTEMS
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. PEGASYSTEMS INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. HEALTHCARE ATHOME
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. COGNIZANT TRIZETTO SOFTWARE GROUP, INC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. IBM CORPORATION
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Allscripts
2. ScienceSoft USA Corporation
3. Siemens Healthcare Private Limited
4. Koninklijke Philips N.V
5. MINES & Associates, Inc.;
6. Mediware Information Systems
7. Pegasystems Inc.
8. HealthCare atHOME
9. Cognizant TriZetto Software Group, Inc
10. IBM Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For